BWXT Medical enters long-term agreement with Boston Scientific to manufacture TheraSphere microspheres

BWXT Medical Ltd. entered into a new long-term, mutually exclusive agreement to manufacture TheraSphere Y-90 Glass Microspheres for Boston Scientific. BWXT Medical will invest to automate production at its Ottawa facility to increase capacity.

“BWXT Medical will invest to automate the production process at its Ottawa, Canada facility, and thereby significantly increase capacity and dependability to support a growing global demand for TheraSphere.”businesswire.com

• 1 source
• businesswire.comBWXT Medical Enters into a New Long-Term Agreement with Boston Scientific for the Manufacture of TheraSphere™ Y-90 Glass MicrospheresBWXT Media ContactMay 10, 2021

Summarized from public sources; check the original articles before acting on it.